BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19299580)

  • 1. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.
    Feng HQ; Weymouth ND; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G27-33. PubMed ID: 19299580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
    Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
    Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.
    Poo JL; Jiménez W; María Muñoz R; Bosch-Marcé M; Bordas N; Morales-Ruiz M; Pérez M; Deulofeu R; Solé M; Arroyo V; Rodés J
    Gastroenterology; 1999 Jan; 116(1):161-7. PubMed ID: 9869614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
    Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
    Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.
    Sacerdoti D; Jiang H; Gaiani S; McGiff JC; Gatta A; Bolognesi M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):72-5. PubMed ID: 21856435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
    Sachidanandam K; Elgebaly MM; Harris AK; Hutchinson JR; Mezzetti EM; Portik-Dobos V; Ergul A
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2743-9. PubMed ID: 18424628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
    Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation.
    Watanabe N; Takashimizu S; Nishizaki Y; Kojima S; Kagawa T; Matsuzaki S
    J Gastroenterol; 2007 Sep; 42(9):775-82. PubMed ID: 17876548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats.
    De Gottardi A; Shaw S; Sägesser H; Reichen J
    J Hepatol; 2000 Nov; 33(5):733-7. PubMed ID: 11097480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats.
    Elliot AJ; Vo LT; Grossman VL; Bhathal PS; Grossman HJ
    J Gastroenterol Hepatol; 1997 Apr; 12(4):314-8. PubMed ID: 9195372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective and non-selective endothelin receptor blockade on ET-1-induced pressor response in the hamster.
    Honoré JC; Fecteau MH; Wessale JL; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S68-71. PubMed ID: 15838362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraportal nicotine infusion in rats decreases hepatic blood flow through endothelin-1 and both endothelin A and endothelin B receptors.
    Hashimoto T; Yoneda M; Shimada T; Kurosawa M; Terano A
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):1-10. PubMed ID: 15050402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
    Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
    Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
    Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.